Angiotensin-(1-7)/Angiotensin-Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms

Angiotensin-(1-7)/Angiotensin-Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms

Saved in:

Bibliographic Details
Main Authors:	Anderson J. Ferreira, Robson A. S. Santos, Mohan K. Raizada
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	International Journal of Hypertension
Online Access:	http://dx.doi.org/10.1155/2012/690785
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis
by: Anderson J. Ferreira, et al.
Published: (2012-01-01)

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2012-01-01)

Angiotensin-Converting Enzyme 2: The First Decade
by: Nicola E. Clarke, et al.
Published: (2012-01-01)

Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study
by: Wei-Fan Hsu, et al.
Published: (2019-01-01)

Biosynthetic Pathways and the Role of the Mas Receptor in the Effects of Angiotensin-(1–7) in Smooth Muscles
by: Marcio Augusto Fressatto de Godoy, et al.
Published: (2012-01-01)

Angiotensin-(1-7)-Mediated Signaling in Cardiomyocytes
by: Enéas R. M. Gomes, et al.
Published: (2012-01-01)

Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01)

The Angiotensin-Melatonin Axis
by: Luciana A. Campos, et al.
Published: (2013-01-01)

Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction
by: Akihiro Sunaga, et al.
Published: (2022-06-01)

Identification and molecular mechanism of angiotensin-converting enzyme inhibitory peptides from Larimichthys crocea titin
by: Yue Fan, et al.
Published: (2020-09-01)

Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19
by: Taravat Talebi, et al.
Published: (2023-01-01)

Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effects of rice peptides
by: Jingjing Dong, et al.
Published: (2022-11-01)

An Angiotensin-converting Enzyme Inhibition Activity by Various Natural Approaches: A Statistic Review
by: Rupal K. Chhaniyara, et al.
Published: (2024-01-01)

Droplet microfluidic screening to engineer angiotensin-converting enzyme 2 (ACE2) catalytic activity
by: Evelyn F Okal, et al.
Published: (2025-02-01)

Study on Fermentation Preparation, Stability, and Angiotensin-Converting Enzyme Inhibitory Activity of Tomato Pomace Peptide
by: Ying Mu, et al.
Published: (2025-01-01)

Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and Literature Review
by: Erin K. Yeung, et al.
Published: (2018-01-01)

Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Small Vessel Cerebral Stroke in Indian Population
by: Puttachandra Prabhakar, et al.
Published: (2014-01-01)

Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats
by: Fúlvia D. Marques, et al.
Published: (2012-01-01)

Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade
by: Avantika Chenna, et al.
Published: (2020-01-01)

Angiotensin-I-Converting Enzyme Inhibitory and Antioxidant Activities of Protein Hydrolysate from Muscle of Barbel (Barbus callensis)
by: Assaad Sila, et al.
Published: (2013-01-01)

The Level of hs-CRP in Coronary Artery Ectasia and Its Response to Statin and Angiotensin-Converting Enzyme Inhibitor Treatment
by: Yilmaz Ozbay, et al.
Published: (2007-01-01)

Efficacy of Administration of an Angiotensin Converting Enzyme Inhibitor for Two Years on Autonomic and Peripheral Neuropathy in Patients with Diabetes Mellitus
by: Triantafyllos Didangelos, et al.
Published: (2017-01-01)

Serum Level of the Angiotensin-Converting Enzyme in Patients with Idiopathic Acute Optic Neuritis: A Case-Control Study
by: Heshmatollah Ghanbari, et al.
Published: (2020-01-01)

Black Trumpet, Craterellus cornucopioides (L.) Pers.: Culinary Mushroom with Angiotensin Converting Enzyme Inhibitory and Cytotoxic Activity
by: Jelena Radović, et al.
Published: (2022-06-01)

Retrospective evaluation of risk factors for worsening renal function after angiotensin‐converting enzyme inhibitor treatment in dogs
by: Yelim Lee, et al.
Published: (2025-01-01)

Angiotensin‐converting enzyme 2 modulation of pyroptosis pathway in traumatic brain injury: A potential therapeutic target
by: Jinxiu Guo, et al.
Published: (2025-01-01)

The Effect of the Concurrent Use of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Toxicity and Outcomes in Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis
by: Wan-Chuen Liao, et al.
Published: (2025-01-01)

Purification of Angiotensin-I-Converting Enzyme Inhibitory Peptides Derived from Camellia oleifera Abel Seed Meal Hydrolysate
by: Guang-long Yao, et al.
Published: (2019-01-01)

Angiotensin-(1-7) and Alamandine Promote Anti-inflammatory Response in Macrophages In Vitro and In Vivo
by: Melissa de Carvalho Santuchi, et al.
Published: (2019-01-01)

Association of Angiotensin I Converting Enzyme Insertion/287 bp Deletion Polymorphisms and Proliferative Prostatic Diseases among Lebanese Men
by: Asmahan A. El Ezzi, et al.
Published: (2020-01-01)

Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors
by: Hajaralsadat Hosseini-Dastgerdi, et al.
Published: (2022-01-01)

Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
by: Michelle A. Clark, et al.
Published: (2013-01-01)

Separation, Purification, and Activity Analysis of Angiotensin Converting Enzyme Inhibitory Peptides in Enzymatically Hydrolyzed Egg Yolk of Chinese Soft-Shelled Turtle
by: LIU Huayu, LIAO Pengying, ZHANG Tianfeng, ZHANG Xinrui, DENG Yunning, LI Yaohua, WEI Jinrui, CHEN Jun
Published: (2025-01-01)

Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice
by: Lawrence Coppey, et al.
Published: (2012-01-01)

Angiotensin-Converting Enzyme 2 Deficiency Aggravates Glucose Intolerance via Impairment of Islet Microvascular Density in Mice with High-Fat Diet
by: Li Yuan, et al.
Published: (2013-01-01)

The Angiotensin II Type 2 Receptor in Brain Functions: An Update
by: Marie-Odile Guimond, et al.
Published: (2012-01-01)

Druggability and molecular docking of essential secondary metabolites from Azadirachta indica leaf against angiotensin converting enzyme-2: Covid-19 in focus
by: Paul Chijioke Ozioko, et al.
Published: (2025-02-01)

Optimization of Protein Hydrolysate from Earthworms (<i>Perionyx excavatus</i>) of Angiotensin-I-Converting Enzyme Inhibitory Activity by One Variable at a Time
by: Phong Thanh Bui, et al.
Published: (2025-01-01)

The Prorenin and (Pro)renin Receptor: New Players in the Brain Renin-Angiotensin System?
by: Wencheng Li, et al.
Published: (2012-01-01)

Elevated Blood Pressure in the Acute Phase of Stroke and the Role of Angiotensin Receptor Blockers
by: Simona Lattanzi, et al.
Published: (2013-01-01)